Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease

Janelle Vu Pugashetti,Dinesh Khanna,Ella A. Kazerooni,Justin Oldham

DOI: https://doi.org/10.1016/j.rdc.2024.03.007

IF: 2.032

2024-06-27

Rheumatic Disease Clinics of North America

Abstract:• Blood-based biomarkers that reflect lung epithelial cell dysfunction, aberrant immunity, and abnormal lung remodeling may discriminate the presence of interstitial lung disease in patients with connective tissue diseases. • High-resolution computed tomography (HRCT) is the current best diagnostic tool for ILD and may have prognostic value in CTD-ILD. • Texture-based and volumetric HRCT analysis show promise as prognostic biomarkers in CTD-ILD. • Composite biomarkers improve risk prediction compared with Blood-based biomarkers that reflect lung epithelial cell dysfunction, aberrant immunity, and abnormal lung remodeling may discriminate the presence of interstitial lung disease in patients with connective tissue diseases. High-resolution computed tomography (HRCT) is the current best diagnostic tool for ILD and may have prognostic value in CTD-ILD. Texture-based and volumetric HRCT analysis show promise as prognostic biomarkers in CTD-ILD. Composite biomarkers improve risk prediction compared with

rheumatology